(Q39574093)

13 September 2017

title

Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression (English)

1 reference

13 September 2017

main subject

cervix uterine cancer

1 reference

Michelle F Maritz

1

1 reference

13 September 2017

Pauline J van der Watt

2

1 reference

13 September 2017

Nina Holderness

3

1 reference

13 September 2017

Michael J Birrer

4

1 reference

13 September 2017

Virna D Leaner

5

1 reference

13 September 2017

publication date

22 March 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

392

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

439-448

1 reference

Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

H(2)O(2)-induced AP-1 activation and its effect on p21(WAF1/CIP1)-mediated G2/M arrest in a p53-deficient human lung cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Celecoxib leads to G2/M arrest by induction of p21 and down-regulation of cyclin B1 expression in a p53-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

AP-1: a double-edged sword in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Molecular targets of the oncogenic transcription factor jun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

NF-kappaB and cell-cycle regulation: the cyclin connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

AP-1 function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Cyclin A is a c-Jun target gene and is necessary for c-Jun-induced anchorage-independent growth in RAT1a cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Alteration of jun proto-oncogene status by plasmid transfection affects growth of human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Control of cell cycle progression by c-Jun is p53 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

AP-1 as a regulator of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.036

21 January 2018

Identifiers

DOI

10.1515/BC.2011.036

1 reference

release_352ah3exx5a4pejg4xcesbsr24

13 September 2017

Fatcat ID

0 references

1 reference